Role of cell cycle in mediating sensitivity to radiotherapy

Jemal, 2003, Cancer statistics, 2003, CA Cancer J Clin, 53, 5, 10.3322/canjclin.53.1.5 Jung, 1996, Signal transduction and cellular responses to ionizing radiation, Semin Radiat Oncol, 6, 268, 10.1016/S1053-4296(96)80022-1 Peters, 1982, Tumor radioresistance in clinical radiotherapy, Int J Radiat Oncol Biol Phys, 8, 101, 10.1016/0360-3016(82)90392-3 Deacon, 1984, The radioresponsiveness of human tumours and the initial slope of the cell survival curve, Radiother Oncol, 2, 317, 10.1016/S0167-8140(84)80074-2 Weichselbaum, 1988, Radioresistant tumor cells are present in head and neck carcinomas that recur after radiotherapy, Int J Radiat Oncol Biol Phys, 15, 575, 10.1016/0360-3016(88)90297-0 Weichselbaum, 1988, Heterogeneity of radiation response of a parent human epidermoid carcinoma cell line and four clones, Int J Radiat Oncol Biol Phys, 14, 907, 10.1016/0360-3016(88)90013-2 Warters, 1977, Radionuclide toxicity in cultured mammalian cells, Radiat Res, 69, 348, 10.2307/3574442 Radford, 1994, Radiation response of mouse lymphoid and myeloid cell lines. Part II. Apoptotic death is shown by all lines examined, Int J Radiat Biol, 65, 217, 10.1080/09553009414550251 Warters, 1992, Radiation-induced apoptosis in a murine T-cell hybridoma, Cancer Res, 52, 883 Hartley, 1995, DNA-dependent protein kinase catalytic subunit, Cell, 82, 849, 10.1016/0092-8674(95)90482-4 Kirchgessner, 1995, DNA-dependent kinase (p350) as a candidate gene for the murine SCID defect, Science, 267, 1178, 10.1126/science.7855601 Valerie, 2003, Regulation and mechanisms of mammalian double-strand break repair, Oncogene, 22, 5792, 10.1038/sj.onc.1206679 Kanaar, 1998, Molecular mechanisms of DNA double strand break repair, Trends Cell Biol, 8, 483, 10.1016/S0962-8924(98)01383-X Haber, 2000, Partners and pathways repairing a double-strand break, Trends Genet, 16, 259, 10.1016/S0168-9525(00)02022-9 Johnson, 2001, Double-strand-break-induced homologous recombination in mammalian cells, Biochem Soc Trans, 29, 196, 10.1042/bst0290196 Morrison, 2000, The controlling role of ATM in homologous recombinational repair of DNA damage, EMBO J, 19, 463, 10.1093/emboj/19.3.463 Lee, 1997, Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle, Mol Cell Biol, 17, 1425, 10.1128/MCB.17.3.1425 Takata, 1998, Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells, EMBO J, 17, 5497, 10.1093/emboj/17.18.5497 Revell, 1983, Radiation-induced chromosome damage in man, 215 Cohen-Jonathan, 1999, How does radiation kill cells?, Curr Opin Chem Biol, 3, 77, 10.1016/S1367-5931(99)80014-3 Vaux, 1997, CED-4—The third horseman of apoptosis, Cell, 90, 389, 10.1016/S0092-8674(00)80497-3 Chao, 1998, BCL-2 family, Annu Rev Immunol, 16, 395, 10.1146/annurev.immunol.16.1.395 Nagata, 1997, Apoptosis by death factor, Cell, 88, 355, 10.1016/S0092-8674(00)81874-7 Bergman, 1997, Radioresistance, chemoresistance, and apoptosis resistance, Vet Clin North Am Small Anim Pract, 27, 47, 10.1016/S0195-5616(97)50005-2 Meyn, 1996, Programmed cell death and radioresistance, Cancer Metastasis Rev, 15, 119, 10.1007/BF00049491 Reed, 1995, Regulation of apoptosis by BCL-2 family proteins and its role in cancer and chemoresistance, Curr Opin Oncol, 7, 541, 10.1097/00001622-199511000-00012 Steel, 2001, The case against apoptosis, Acta Oncol, 40, 968, 10.1080/02841860152708251 Steel GG. Clonogenic cells and the concept of cell survival. In: Steel GG, editor. Basic clinical radiobiology. London: Arnold; 2002. p. 52–54 Fei, 2002, Tissue-specific induction of p53 targets in vivo, Cancer Res, 62, 7316 Yonish-Rouach, 1993, p53-mediated cell death, Mol Cell Biol, 13, 1415, 10.1128/MCB.13.3.1415 Yonish-Rouach, 1991, Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6, Nature, 352, 345, 10.1038/352345a0 Sabbatini, 1995, Essential role for p53-mediated transcription in E1A-induced apoptosis, Genes Dev, 9, 2184, 10.1101/gad.9.17.2184 Haupt, 1995, p53-mediated apoptosis in HeLa cells can be overcome by excess pRB, Oncogene, 10, 1563 Caelles, 1994, p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes, Nature, 370, 220, 10.1038/370220a0 Attardi, 1996, Transcriptional activation by p53, but not induction of the p21 gene, is essential for oncogene-mediated apoptosis, EMBO J, 15, 3693, 10.1002/j.1460-2075.1996.tb00739.x Wagner, 1994, Myc-mediated apoptosis requires wild-type p53 in a manner independent of cell cycle arrest and the ability of p53 to induce p21waf1/cip1, Genes Dev, 8, 2817, 10.1101/gad.8.23.2817 Owen-Schaub, 1995, Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression, Mol Cell Biol, 15, 3032, 10.1128/MCB.15.6.3032 Muller, 1998, p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs, J Exp Med, 188, 2033, 10.1084/jem.188.11.2033 Wu, 1997, KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene, Nat Genet, 17, 141, 10.1038/ng1097-141 Lin, 2000, PIDD, a new death-domain-containing protein, is induced by p53 and promotes apoptosis, Nat Genet, 26, 122, 10.1038/79102 Polyak, 1997, A model for p53-induced apoptosis, Nature, 389, 300, 10.1038/38525 Mihara, 2003, p53 has a direct apoptogenic role at the mitochondria, Mol Cell, 11, 577, 10.1016/S1097-2765(03)00050-9 Fei, 2003, p53 and radiation responses, Oncogene, 22, 5774, 10.1038/sj.onc.1206677 Kolesnick, 1994, The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation, Biochem Cell Biol, 72, 471, 10.1139/o94-063 Yoshimura, 1998, Ceramide formation leads to caspase-3 activation during hypoxic PC12 cell death, J Biol Chem, 273, 6921, 10.1074/jbc.273.12.6921 Chen, 1995, Suppression of BCL-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide, Cancer Res, 55, 991 Michael, 1997, Resistance to radiation-induced apoptosis in Burkitt's lymphoma cells is associated with defective ceramide signaling, Cancer Res, 57, 3600 Samuel, 2002, Linking DNA damage to cell cycle checkpoints, Cell Cycle, 1, 162, 10.4161/cc.1.3.118 Banin, 1998, Enhanced phosphorylation of p53 by ATM in response to DNA damage, Science, 281, 1674, 10.1126/science.281.5383.1674 Canman, 1998, Activation of the ATM kinase by ionizing radiation and phosphorylation of p53, Science, 281, 1677, 10.1126/science.281.5383.1677 Westphal, 1997, Cell-cycle signaling, Curr Biol, 7, R789, 10.1016/S0960-9822(06)00406-4 Hoekstra, 1997, Responses to DNA damage and regulation of cell cycle checkpoints by the ATM protein kinase family, Curr Opin Genet Dev, 7, 170, 10.1016/S0959-437X(97)80125-6 Bakkenist, 2003, DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation, Nature, 421, 499, 10.1038/nature01368 Collis, 2003, Enhanced radiation and chemotherapy-mediated cell killing of human cancer cells by small inhibitory RNA silencing of DNA repair factors, Cancer Res, 63, 1550 Meyn, 1995, Ataxia-telangiectasia and cellular responses to DNA damage, Cancer Res, 55, 5991 Lees-Miller, 1995, Absence of p350 subunit of DNA-activated protein kinase from a radiosensitive human cell line, Science, 267, 1183, 10.1126/science.7855602 Shiloh, 2001, ATM and ATR, Curr Opin Genet Dev, 11, 71, 10.1016/S0959-437X(00)00159-3 Kastan, 1995, Ataxia-telangiectasia–broad implications for a rare disorder, N Engl J Med, 333, 662, 10.1056/NEJM199509073331014 Lavin, 1997, The genetic defect in ataxia-telangiectasia, Annu Rev Immunol, 15, 177, 10.1146/annurev.immunol.15.1.177 Kastan, 1992, A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia, Cell, 71, 587, 10.1016/0092-8674(92)90593-2 Paules, 1995, Defective G2 checkpoint function in cells from individuals with familial cancer syndromes, Cancer Res, 55, 1763 Giaccia, 1998, The complexity of p53 modulation, Genes Dev, 12, 2973, 10.1101/gad.12.19.2973 Kapoor, 2000, Cooperative phosphorylation at multiple sites is required to activate p53 in response to UV radiation, Oncogene, 19, 358, 10.1038/sj.onc.1203300 Shieh, 1997, DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2, Cell, 91, 325, 10.1016/S0092-8674(00)80416-X Haupt, 1997, MDM2 promotes the rapid degradation of p53, Nature, 387, 296, 10.1038/387296a0 Kubbutat, 1997, Regulation of p53 stability by MDM2, Nature, 387, 299, 10.1038/387299a0 Lane, 1997, MDM2—Arbiter of p53's destruction, Trends Biochem Sci, 22, 372, 10.1016/S0968-0004(97)01119-5 Maltzman, 1984, UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells, Mol Cell Biol, 4, 1689, 10.1128/MCB.4.9.1689 Maki, 1997, Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation, Mol Cell Biol, 17, 355, 10.1128/MCB.17.1.355 Price, 1993, Increased sequence-specific p53-DNA binding activity after DNA damage is attenuated by phorbol esters, Oncogene, 8, 3055 Chen, 1996, p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells, Genes Dev, 10, 2438, 10.1101/gad.10.19.2438 Levine, 1997, p53, the cellular gatekeeper for growth and division, Cell, 88, 323, 10.1016/S0092-8674(00)81871-1 Shieh, 2000, The human homologs of checkpoint kinases CHK1 and Cds1 (CHK2) phosphorylate p53 at multiple DNA damage-inducible sites, Genes Dev, 14, 289, 10.1101/gad.14.3.289 Chehab, 2000, CHK2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53, Genes Dev, 14, 278, 10.1101/gad.14.3.278 Matsuoka, 1998, Linkage of ATM to cell cycle regulation by the CHK2 protein kinase, Science, 282, 1893, 10.1126/science.282.5395.1893 Herzinger, 1995, Ultraviolet B irradiation-induced G2 cell cycle arrest in human keratinocytes by inhibitory phosphorylation of the cdc2 cell cycle kinase, Oncogene, 11, 2151 Cortez, 1999, Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks, Science, 286, 1162, 10.1126/science.286.5442.1162 Gatei, 2000, ATM-dependent phosphorylation of nibrin in response to radiation exposure, Nat Genet, 25, 115, 10.1038/75508 Gatei, 2000, Role for ATM in DNA damage-induced phosphorylation of BRCA1, Cancer Res, 60, 3299 Li, 2000, Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response, Nature, 406, 210, 10.1038/35018134 Lim, 2000, ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway, Nature, 404, 613, 10.1038/35007091 Wu, 2000, ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response, Nature, 405, 477, 10.1038/35013089 Zhao, 2000, Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products, Nature, 405, 473, 10.1038/35013083 Powell, 2003, Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation, Oncogene, 22, 5784, 10.1038/sj.onc.1206678 Chen, 2001, ATM-dependent phosphorylation of human Rad9 is required for ionizing radiation-induced checkpoint activation, J Biol Chem, 276, 16580, 10.1074/jbc.M008871200 Carney, 1998, The hMre11/hRad50 protein complex and Nijmegen breakage syndrome, Cell, 93, 477, 10.1016/S0092-8674(00)81175-7 Varon, 1998, Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome, Cell, 93, 467, 10.1016/S0092-8674(00)81174-5 Featherstone, 1998, DNA repair, Curr Biol, 8, R622, 10.1016/S0960-9822(98)70392-6 Shiloh, 1997, Ataxia-telangiectasia and the Nijmegen breakage syndrome, Annu Rev Genet, 31, 635, 10.1146/annurev.genet.31.1.635 Xu, 1999, Centrosome amplification and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells, Mol Cell, 3, 389, 10.1016/S1097-2765(00)80466-9 Moynahan, 1999, BRCA1 controls homology-directed DNA repair, Mol Cell, 4, 511, 10.1016/S1097-2765(00)80202-6 Ouchi, 1998, BRCA1 regulates p53-dependent gene expression, Proc Natl Acad Sci USA, 95, 2302, 10.1073/pnas.95.5.2302 Somasundaram, 1997, Arrest of the cell cycle by the tumour-suppressor BRCA1 requires the CDK-inhibitor p21WAF1/CiP1, Nature, 389, 187, 10.1038/38291 Harkin, 1999, Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1, Cell, 97, 575, 10.1016/S0092-8674(00)80769-2 Koonin, 1996, BRCA1 protein products, Nat Genet, 13, 266, 10.1038/ng0796-266 Paulovich, 1995, A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage, Cell, 82, 841, 10.1016/0092-8674(95)90481-6 Siede, 1993, RAD9-dependent G1 arrest defines a second checkpoint for damaged DNA in the cell cycle of Saccharomyces cerevisiae, Proc Natl Acad Sci USA, 90, 7985, 10.1073/pnas.90.17.7985 Weinert, 1988, The RAD9 gene controls the cell cycle response to DNA damage in Saccharomyces cerevisiae, Science, 241, 317, 10.1126/science.3291120 Weinert, 1990, Characterization of RAD9 of Saccharomyces cerevisiae and evidence that its function acts posttranslationally in cell cycle arrest after DNA damage, Mol Cell Biol, 10, 6554, 10.1128/MCB.10.12.6554 Sheikh, 2000, Role of GADD45 in apoptosis, Biochem Pharmacol, 59, 43, 10.1016/S0006-2952(99)00291-9 Takekawa, 1998, A family of stress-inducible GADD45-like proteins mediate activation of the stress-responsive MTK1/MEKK4 MAPKKK, Cell, 95, 521, 10.1016/S0092-8674(00)81619-0 Brugarolas, 1999, Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation, Proc Natl Acad Sci USA, 96, 1002, 10.1073/pnas.96.3.1002 Sherr, 1999, CDK inhibitors, Genes Dev, 13, 1501, 10.1101/gad.13.12.1501 Adams, 1996, Identification of a cyclin-CDK2 recognition motif present in substrates and p21-like cyclin-dependent kinase inhibitors, Mol Cell Biol, 16, 6623, 10.1128/MCB.16.12.6623 Zhu, 1995, p107 uses a p21CIP1-related domain to bind cyclin/CDK2 and regulate interactions with E2F, Genes Dev, 9, 1740, 10.1101/gad.9.14.1740 Chen, 1996, Cyclin-binding motifs are essential for the function of p21CIP1, Mol Cell Biol, 16, 4673, 10.1128/MCB.16.9.4673 Stewart, 2001, p53 Signaling and cell cycle checkpoints, Chem Res Toxicol, 14, 243, 10.1021/tx000199t Hartwell, 1994, Cell cycle control and cancer, Science, 266, 1821, 10.1126/science.7997877 Hartwell, 1989, Checkpoints, Science, 246, 629, 10.1126/science.2683079 Kaufmann, 1996, DNA damage and cell cycle checkpoints, FASEB J, 10, 238, 10.1096/fasebj.10.2.8641557 Xu, 2002, Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation, Mol Cell Biol, 22, 1049, 10.1128/MCB.22.4.1049-1059.2002 Marples, 2003, An association between the radiation-induced arrest of G2-phase cells and low-dose hyper-radiosensitivity, Radiat Res, 160, 38, 10.1667/RR3013 Li, 1995, Diminished capacity for p53 in mediating a radiation-induced G1 arrest in established human tumor cell lines, Oncogene, 11, 1885 Little, 1995, Absence of radiation-induced G1 arrest in two closely related human lymphoblast cell lines that differ in p53 status, J Biol Chem, 270, 11033, 10.1074/jbc.270.19.11033 Nagasawa, 1995, Relationship between radiation-induced G1 phase arrest and p53 function in human tumor cells, Cancer Res, 55, 1842 Pellegata, 1996, DNA damage and p53-mediated cell cycle arrest, Proc Natl Acad Sci USA, 93, 15209, 10.1073/pnas.93.26.15209 Kastan, 1991, Participation of p53 protein in the cellular response to DNA damage, Cancer Res, 51, 6304 Taylor, 2001, Regulation of the G2/M transition by p53, Oncogene, 20, 1803, 10.1038/sj.onc.1204252 Bache, 1999, G2/M checkpoint is p53-dependent and independent after irradiation in five human sarcoma cell lines, Anticancer Res, 19, 1827 Bunz, 1998, Requirement for p53 and p21 to sustain G2 arrest after DNA damage, Science, 282, 1497, 10.1126/science.282.5393.1497 Nagasawa, 1994, Relationship between gamma-ray-induced G2/M delay and cellular radiosensitivity, Int J Radiat Biol, 66, 373, 10.1080/09553009414551311 Fingert, 1986, Cytotoxic, cell cycle, and chromosomal effects of methylxanthines in human tumor cells treated with alkylating agents, Cancer Res, 46, 2463 Strunz, 2002, Preferential radiosensitization in p53-mutated human tumour cell lines by pentoxifylline-mediated disruption of the G2/M checkpoint control, Int J Radiat Biol, 78, 721, 10.1080/09553000210141667 Theron, 2000, The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline, Int J Radiat Biol, 76, 1197, 10.1080/09553000050134438 Asaad, 2000, Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells, Oncogene, 19, 5788, 10.1038/sj.onc.1203953 Koniaras, 2001, Inhibition of CHK1-dependent G2 DNA damage checkpoint radiosensitizes p53 mutant human cells, Oncogene, 20, 7453, 10.1038/sj.onc.1204942 Graves, 2000, The Chk1 protein kinase and the Cdc25C regulatory pathways are targets of the anticancer agent UCN-01, J Biol Chem, 275, 5600, 10.1074/jbc.275.8.5600 Jackson, 2000, An indolocarbazole inhibitor of human checkpoint kinase (CHK1) abrogates cell cycle arrest caused by DNA damage, Cancer Res, 60, 566 Mizuno, 1995, UCN-01, an anti-tumor drug, is a selective inhibitor of the conventional PKC subfamily, FEBS Lett, 359, 259, 10.1016/0014-5793(95)00042-8 Akinaga, 1991, Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models, Cancer Res, 51, 4888 Akiyama, 1997, G1 phase accumulation induced by UCN-01 is associated with dephosphorylation of Rb and CDK2 proteins as well as induction of CDK inhibitor p21/Cip1/WAF1/Sdi1 in p53-mutated human epidermoid carcinoma A431 cells, Cancer Res, 57, 1495 Wang, 1996, UCN-01, J Natl Cancer Inst, 88, 956, 10.1093/jnci/88.14.956 Hsueh, 1998, UCN-01 suppresses thymidylate synthase gene expression and enhances 5-fluorouracil-induced apoptosis in a sequence-dependent manner, Clin Cancer Res, 4, 2201 Shao, 1997, Abrogation of an S-phase checkpoint and potentiation of camptothecin cytotoxicity by 7-hydroxystaurosporine (UCN-01) in human cancer cell lines, possibly influenced by p53 function, Cancer Res, 57, 4029 Hirose, 2001, Abrogation of the CHK1-mediated G(2) checkpoint pathway potentiates temozolomide-induced toxicity in a p53-independent manner in human glioblastoma cells, Cancer Res, 61, 5843 Sausville, 2003, Signal transduction—Directed cancer treatments, Annu Rev Pharmacol Toxicol, 43, 199, 10.1146/annurev.pharmtox.43.100901.135813 Busby, 2000, The radiosensitizing agent 7-hydroxystaurosporine (UCN-01) inhibits the DNA damage checkpoint kinase hChk1, Cancer Res, 60, 2108 Senderowicz, 2000, Preclinical and clinical development of cyclin-dependent kinase modulators, J Natl Cancer Inst, 92, 376, 10.1093/jnci/92.5.376 Kwon, 2000, Effect of pentoxifylline on radiation response of non-small cell lung cancer, Radiother Oncol, 56, 175, 10.1016/S0167-8140(00)00221-8 Dai, 2003, Cyclin-dependent kinase inhibitors, Curr Opin Pharmacol, 3, 362, 10.1016/S1471-4892(03)00079-1 Jia, 2003, Synergistic antileukemic interactions between 17-AAG and UCN-01 involve interruption of RAF/MEK- and AKT-related pathways, Blood, 102, 1824, 10.1182/blood-2002-12-3785 Sausville, 2001, Phase I trial of 72-hour continuous infusion UCN-01 in patients with refractory neoplasms, J Clin Oncol, 19, 2319, 10.1200/JCO.2001.19.8.2319 Fuse, 1998, Unpredicted clinical pharmacology of UCN-01 caused by specific binding to human alpha1-acid glycoprotein, Cancer Res, 58, 3248 Little, 1994, Failla Memorial lecture, Radiat Res, 140, 299, 10.2307/3579106 Cross, 1995, A p53-dependent mouse spindle checkpoint, Science, 267, 1353, 10.1126/science.7871434 Lee, 1993, p53 mutations increase resistance to ionizing radiation, Proc Natl Acad Sci USA, 90, 5742, 10.1073/pnas.90.12.5742 Wenz, 1997, Lack of uncoupling of S phase and mitosis after irradiation in p53-human lymphoblast cell lines, Radiat Res, 148, 129, 10.2307/3579569 Nagasawa, 1998, Absence of a radiation-induced first-cycle G1-S arrest in p53+ human tumor cells synchronized by mitotic selection, Cancer Res, 58, 2036 Huang, 1996, Abrogation of P53 function by transfection of HPV16 E6 gene does not enhance resistance of human tumour cells to ionizing radiation, Int J Radiat Biol, 70, 151, 10.1080/095530096145148 Bristow, 1998, Radioresistant MTp53-expressing rat embryo cell transformants exhibit increased DNA-dsb rejoining during exposure to ionizing radiation, Oncogene, 16, 1789, 10.1038/sj.onc.1201935 Wouters, 1997, Loss of p21Waf1/Cip1 sensitizes tumors to radiation by an apoptosis-independent mechanism, Cancer Res, 57, 4703 Waldman, 1997, Cell cycle arrest versus cell death in cancer therapy, Nat Med, 3, 1034, 10.1038/nm0997-1034 Fan, 1997, Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustard, Oncogene, 14, 2127, 10.1038/sj.onc.1201052 Wang, 1997, Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in ATM-deficient mice, Proc Natl Acad Sci USA, 94, 14590, 10.1073/pnas.94.26.14590 Sinclair, 1963, Variations in response during the division cycle of partially synchronized Chinese hamster cells in culture, Nature, 199, 1158, 10.1038/1991158a0 Sinclair, 1965, X-ray and ultraviolet sensitivity of synchronized Chinese hamster cells at various stages of the cell cycle, Biophys J, 5, 1, 10.1016/S0006-3495(65)86700-5 Terasima, 1963, Variations in several responses of HeLa cells to X-irradiation during the division cycle, Biophys J, 3, 11, 10.1016/S0006-3495(63)86801-0 Terasima, 1963, X-ray sensitivity and DNA synthesis in synchronous populations of HeLa cells, Science, 140, 490, 10.1126/science.140.3566.490 Tolmach, 1965, X-ray sensitivity during the division cycle of HeLa S3 cells and anomalous survival kinetics of developing microcolonies, 376 Sinclair, 1966, X-ray sensitivity during the cell generation cycle of cultured Chinese hamster cells, Radiat Res, 29, 450, 10.2307/3572025 Sinclair, 1968, Cyclic X-ray responses in mammalian cells in vitro, Radiat Res, 33, 620, 10.2307/3572419 Carlson, 1969, X-ray-induced prophase delay and reversion of selected cells in certain avian and mammalian tissues in culture, Radiat Res, 37, 15, 10.2307/3572748 Terasima, 1961, Changes in X-ray sensitivity of HeLa cells during the division cycle, Nature, 190, 1210, 10.1038/1901210a0 Mak, 1963, The effects of X-rays on the progress of L cells through the cell cycle, Radiat Res, 20, 600, 10.2307/3571352 Makino, 1975, Effects of ionizing radiation on DNA replications in cultured mammalian cells, Radiat Res, 62, 37, 10.2307/3574182 Dewey, 1962, Relative radiosensitivity of different phases in the life-cycle of L-P mouse fibroblasts and ascites tumor cells, Radiat Res, 16, 503, 10.2307/3571085 Schaer, 1973, Studies on the division cycle of mammalian cells. VII. X-ray sensitivity and repair capacity of synchronously dividing murine mastocytoma cells, Radiat Res, 56, 258, 10.2307/3573664 Elkind, 1963, Radiation response of mammalian cells grown in culture. IV. Dose dependence of division delay and post-irradiation growth of surviving and non-surviving Chinese hamster cells, J Natl Cancer Inst, 30, 705 Elkind M. Sublethal X-ray damage and its repair in mammalian cells. In: Proceedings of the Third International Congress of Radiation Research. Amsterdam: North-Holland Publishing; 1966. p. 558–586 Sinclair, 1967, Hydroxyurea, Cancer Res, 27, 297 Koritzinsky, 1998, Survival of synchronized human NHIK 3025 cells irradiated aerobically following a prolonged treatment with extremely hypoxic conditions, Int J Radiat Biol, 74, 491, 10.1080/095530098141366 Wlodek, 1988, The relationship of DNA and chromosome damage to survival of synchronized X-irradiated L5178Y cells. I. Initial damage, Radiat Res, 115, 550, 10.2307/3577304 Meistrich, 1977, Separation of spermatogenic cells and nuclei from rodent testes, Methods Cell Biol, 15, 15, 10.1016/S0091-679X(08)60207-1 Meistrich, 1977, Synchronization of mouse L-P59 cells by centrifugal elutriation separation, Exp Cell Res, 105, 169, 10.1016/0014-4827(77)90163-X Herzenberg, 2002, The history and future of the fluorescence activated cell sorter and flow cytometry, Clin Chem, 48, 1819, 10.1093/clinchem/48.10.1819 Formenti, 1999, Concurrent paclitaxel and radiation therapy for breast cancer, Semin Radiat Oncol, 9, 34 Hennequin, 1996, Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells, Cancer Res, 56, 1842 Kano, 1998, Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines, Oncol Res, 10, 347 Van Leeuwen-Stok, 1998, Cell cycle dependency of 67gallium uptake and cytotoxicity in human cell lines of hematological malignancies, Leuk Lymphoma, 31, 533, 10.3109/10428199809057612 Wang, 1998, Effect of bryostatin 1 on Taxol-induced apoptosis and cytotoxicity in human leukemia cells (U937), Biochem Pharmacol, 56, 635, 10.1016/S0006-2952(98)00188-9 Zoli, 1999, Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines, Int J Cancer, 80, 413, 10.1002/(SICI)1097-0215(19990129)80:3<413::AID-IJC13>3.0.CO;2-I Price, 1977, A kinetically based logical approach to the chemotherapy of head and neck cancer, Clin Otolaryngol, 2, 339, 10.1111/j.1365-2273.1977.tb01377.x Minarik, 1994, Taxol in combination with acute and low dose rate irradiation, Radiother Oncol, 32, 124, 10.1016/0167-8140(94)90098-1 Millar, 1976, Sparing effect of cyclophosphamide (NSC-26271) pretreatment on animals lethally treated with gamma-irradiation, Cancer Treat Rep, 60, 409 Millar, 1978, Enhanced post-irradiation recovery of the haemopoietic system in animals pretreated with a variety of cytotoxic agents, Cell Tissue Kinet, 11, 543 Wenz, 1999, Radiochemotherapy with paclitaxel, Strahlenther Onkol, 175, 2, 10.1007/BF03215919 Gupta, 1997, Cytotoxicity and cell-cycle effects of paclitaxel when used as a single agent and in combination with ionizing radiation, Int J Radiat Oncol Biol Phys, 37, 885, 10.1016/S0360-3016(96)00535-4 Steren, 1993, Taxol sensitizes human ovarian cancer cells to radiation, Gynecol Oncol, 48, 252, 10.1006/gyno.1993.1043 Tishler, 1992, Taxol sensitizes human astrocytoma cells to radiation, Cancer Res, 52, 3495 Dey, 2003, Low-dose fractionated radiation potentiates the effects of paclitaxel in wild-type and mutant p53 head and neck tumor cell lines, Clin Cancer Res, 9, 1557 Pradier, 1999, Effects of paclitaxel in combination with radiation on human head and neck cancer cells (ZMK-1), cervical squamous cell carcinoma (CaSki), and breast adenocarcinoma cells (MCF-7), J Cancer Res Clin Oncol, 125, 20, 10.1007/s004320050237 Lawrence, 2003, The mechanism of action of radiosensitization of conventional chemotherapeutic agents, Semin Radiat Oncol, 13, 13, 10.1053/srao.2003.50002 Byfield, 1990, Useful interactions between 5-fluorouracil and radiation in man: 5-fluorouracil as a radiosensitizer, 87 Ostruszka, 2000, The role of cell cycle progression in radiosensitization by 2′,2′-difluoro-2′-deoxycytidine, Cancer Res, 60, 6080 Latz, 1998, Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro, Int J Radiat Oncol Biol Phys, 41, 875, 10.1016/S0360-3016(98)00105-9 Raju, 2003, Flavopiridol, a cyclin-dependent kinase inhibitor, enhances radiosensitivity of ovarian carcinoma cells, Cancer Res, 63, 3263 Barranco, 1973, Bleomycin as a possible synchronizing agent for human tumor cells in vivo, Cancer Res, 33, 882 Neil, 1973, The effect of dose interval on the survival of L1210 leukemic mice treated with DNA synthesis inhibitors, Cancer Res, 33, 895 Steel, 1994, Cell synchronization unfortunately may not benefit cancer therapy, Radiother Oncol, 32, 95, 10.1016/0167-8140(94)90094-9 Price, 1978, Improved results in combination chemotherapy of head and neck cancer using a kinetically-based approach, Oncology, 35, 26, 10.1159/000225250 Ngo, 1988, Sequential exposures of mammalian cells to low- and high-LET radiations. II. As a function of cell cycle stages, Radiat Res, 115, 54, 10.2307/3577055 Leeper, 1973, Radiation-induced cycle delay in synchronized Chinese hamster cells, Radiat Res, 53, 326, 10.2307/3573538 Gragg, 1978, The response of Chinese hamster ovary cells to fast neutron radiotherapy beams. III. Variation in biological effectiveness with position in the cell cycle, Radiat Res, 76, 283, 10.2307/3574779 Kal, 1975, Cell cycle progression of murine sarcoma cells after X irradiation or heat shock, Radiology, 117, 215, 10.1148/117.1.215 Ngo, 1983, Effects of mammalian cells of fractionated heavy-ion doses, 251 Geldof, 2003, Cell cycle perturbations and radiosensitization effects in a human prostate cancer cell line, J Cancer Res Clin Oncol, 129, 175, 10.1007/s00432-002-0412-8 Elkind, 1997, Cell cycle sensitivity, recovery from radiation damage and a new paradigm for risk assessment, Int J Radiat Biol, 71, 657, 10.1080/095530097143662 Lucke-Huhle, 1979, Drastic G2 arrest in mammalian cells after irradiation with heavy-ion beams, Radiat Res, 79, 97, 10.2307/3575025 Bartkowiak, 2001, Cell cycle and growth response of CHO cells to X-irradiation, Int J Radiat Oncol Biol Phys, 50, 221, 10.1016/S0360-3016(01)01455-9 Marples, 1993, The response of Chinese hamster V79 cells to low radiation doses, Radiat Res, 133, 41, 10.2307/3578255 Wouters, 1994, The response of a human tumor cell line to low radiation doses, Radiat Res, 138, S76, 10.2307/3578767 Short, 1999, Low dose hypersensitivity in the T98G human glioblastoma cell line, Int J Radiat Biol, 75, 847, 10.1080/095530099139908 Wouters, 1996, Low-dose hypersensitivity and increased radioresistance in a panel of human tumor cell lines with different radiosensitivity, Radiat Res, 146, 399, 10.2307/3579302 Joiner, 1996, Hypersensitivity to very-low single radiation doses, Mutat Res, 358, 171, 10.1016/S0027-5107(96)00118-2 Hendrikse, 2000, Effects of low dose irradiation on TK6 and U937 cells, Int J Radiat Biol, 76, 11, 10.1080/095530000138961 Crompton, 1998, Programmed cellular response to ionizing radiation damage, Acta Oncol, 37, 129, 10.1080/028418698429685 Short, 2003, Effects of cell cycle phase on low-dose hyper-radiosensitivity, Int J Radiat Biol, 79, 99, 10.1080/713865036 Joiner, 2001, Low-dose hypersensitivity, Int J Radiat Oncol Biol Phys, 49, 379, 10.1016/S0360-3016(00)01471-1 Joiner, 1994, Evidence for induced radioresistance from survival and other end points, Radiat Res, 138, S5, 10.2307/3578749 Wlodek, 1988, The relationship of DNA and chromosome damage to survival of synchronized X-irradiated L5178Y cells. II. Repair, Radiat Res, 115, 566, 10.2307/3577305 Tallon, 1998, Cell cycle dependent aneuploidy induction by X-rays in vitro in human lymphocytes, Microsc Res Tech, 40, 344, 10.1002/(SICI)1097-0029(19980301)40:5<344::AID-JEMT2>3.0.CO;2-R Humar, 2001, Cell cycle dependent DNA break increase in ataxia telangiectasia lymphoblasts after radiation exposure, Mol Pathol, 54, 347, 10.1136/mp.54.5.347 Paglin, 1997, Radiation-induced micronuclei formation in human breast cancer cells, Biochem Biophys Res Commun, 237, 678, 10.1006/bbrc.1997.7117 Durante, 1994, Radiation-induced chromosomal aberrations in mouse 10T1/2 cells, Int J Radiat Biol, 65, 437, 10.1080/09553009414550511 Iliakis, 1990, Radiosensitivity throughout the cell cycle and repair of potentially lethal damage and DNA double-strand breaks in an X-ray-sensitive CHO mutant, Int J Radiat Biol, 57, 1195, 10.1080/09553009014551291 Bender, 1974, Mechanisms of chromosomal aberration production. 3. Chemicals and ionizing radiation, Mutat Res, 23, 197, 10.1016/0027-5107(74)90140-7 Geard, 1985, Charged particle cytogenetics, Radiat Res Suppl, 8, S112, 10.2307/3583518 Biade, 1997, The intrinsic radiosensitivity of some human tumor cells throughout their cell cycles, Radiat Res, 147, 416, 10.2307/3579497 Deschavanne, 1996, A review of human cell radiosensitivity in vitro, Int J Radiat Oncol Biol Phys, 34, 251, 10.1016/0360-3016(95)02029-2 Tutt, 2003, Cell cycle and genetic background dependence of the effect of loss of BRCA2 on ionizing radiation sensitivity, Oncogene, 22, 2926, 10.1038/sj.onc.1206522 Van Putten, 1976, Synchronization in tumour chemotherapy, Eur J Cancer, 12, 79, 10.1016/0014-2964(76)90209-7 Tannock, 1978, Cell kinetics and chemotherapy, Cancer Treat Rep, 62, 1117 Tubiana, 1982, Gray Medal lecture, Int J Radiat Oncol Biol Phys, 8, 1471, 10.1016/0360-3016(82)90607-1 Tubiana, 1975, Critical survey of experimental data on in vivo synchronization by hydroxyurea, 187, 10.1007/978-3-642-80940-8_22 Steel, 1977 Skladowski, 1993, Cell cycle progression during continuous low dose rate irradiation of a human bladder carcinoma cell line, Radiother Oncol, 28, 219, 10.1016/0167-8140(93)90061-C